The Asia Pacific Dermocosmetics Market is expected to witness market growth of 10.2% CAGR during the forecast period (2022-2028).
Dermocosmetics are nonetheless cosmetics and must be distinguished from medications notwithstanding the stringent standards placed on their quality. Dermocosmetics is the field that gave origin to the more recent marketing term "cosmeceutical." Cosmeceuticals, like dermocosmetics, are medical-dermatological skincare items that promise to keep the function of the skin the same or even enhance it. But frequently, goods are already referred to as cosmeceuticals since they have cutting-edge, high-tech active components.
In the beginning, dermo-cosmetics were specialist skincare products created with dermatologists' assistance to help enhance the appearance of the skin while treating a variety of skin conditions like redness, acne, inflammation, and more. They are created after substantial research and frequently use cutting-edge materials and equipment. Because they are specifically created to prevent and cure particular types of skin diseases, these products set themselves apart from everyday skin care products. To ensure that the formulations have the intended impact on the problem they are intended to solve, they are clinically tested.
In terms of beauty and personal care, Asia Pacific is expected to be the largest area in 2021. At least two-thirds of the absolute value growth in beauty and personal care products during the predicted period may be attributed to the area. Many of the factors driving the region's growth include rising disposable incomes, quick e-commerce growth before the pandemic, significant customer demand for skincare, and developing interest in less-popular color cosmetics and fragrance categories. The COVID outbreak has accelerated public awareness of skin health issues and increased demand for solutions with clinical evidence of their efficacy.
The China market dominated the Asia Pacific Dermocosmetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $9,547.5 Million by 2028.The Japan market is estimated to grow a CAGR of 9.6% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 10.9% during (2022 - 2028).
Based on Product, the market is segmented into Skin Care and Hair Care. Based on Distribution Channel, the market is segmented into Pharmacy & Retail Stores and Online. Based on End User, the market is segmented into Clinics, Medical Spas, & Salons, Hospitals and At-Home. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Galderma S.A., The Procter and Gamble Company, Allergan plc, L'Oreal Group, Beiersdorf AG, Kao Corporation (Kanebo Cosmetics Inc.), Estee Lauder Companies Inc., and Shiseido Company.
Dermocosmetics are nonetheless cosmetics and must be distinguished from medications notwithstanding the stringent standards placed on their quality. Dermocosmetics is the field that gave origin to the more recent marketing term "cosmeceutical." Cosmeceuticals, like dermocosmetics, are medical-dermatological skincare items that promise to keep the function of the skin the same or even enhance it. But frequently, goods are already referred to as cosmeceuticals since they have cutting-edge, high-tech active components.
In the beginning, dermo-cosmetics were specialist skincare products created with dermatologists' assistance to help enhance the appearance of the skin while treating a variety of skin conditions like redness, acne, inflammation, and more. They are created after substantial research and frequently use cutting-edge materials and equipment. Because they are specifically created to prevent and cure particular types of skin diseases, these products set themselves apart from everyday skin care products. To ensure that the formulations have the intended impact on the problem they are intended to solve, they are clinically tested.
In terms of beauty and personal care, Asia Pacific is expected to be the largest area in 2021. At least two-thirds of the absolute value growth in beauty and personal care products during the predicted period may be attributed to the area. Many of the factors driving the region's growth include rising disposable incomes, quick e-commerce growth before the pandemic, significant customer demand for skincare, and developing interest in less-popular color cosmetics and fragrance categories. The COVID outbreak has accelerated public awareness of skin health issues and increased demand for solutions with clinical evidence of their efficacy.
The China market dominated the Asia Pacific Dermocosmetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $9,547.5 Million by 2028.The Japan market is estimated to grow a CAGR of 9.6% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 10.9% during (2022 - 2028).
Based on Product, the market is segmented into Skin Care and Hair Care. Based on Distribution Channel, the market is segmented into Pharmacy & Retail Stores and Online. Based on End User, the market is segmented into Clinics, Medical Spas, & Salons, Hospitals and At-Home. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Galderma S.A., The Procter and Gamble Company, Allergan plc, L'Oreal Group, Beiersdorf AG, Kao Corporation (Kanebo Cosmetics Inc.), Estee Lauder Companies Inc., and Shiseido Company.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Skin Care
- Hair Care
By Distribution Channel
- Pharmacy & Retail Stores
- Online
By End User
- Clinics, Medical Spas, & Salons
- Hospitals
- At-Home
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Bausch Health Companies
- Galderma S.A.
- The Procter and Gamble Company
- Allergan plc
- L'Oreal Group
- Beiersdorf AG
- Kao Corporation (Kanebo Cosmetics Inc.)
- Estee Lauder Companies Inc.
- Shiseido Company
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Dermocosmetics Market by Product
Chapter 5. Asia Pacific Dermocosmetics Market by Distribution Channel
Chapter 6. Asia Pacific Dermocosmetics Market by End User
Chapter 7. Asia Pacific Dermocosmetics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Johnson & Johnson
- Bausch Health Companies
- Galderma S.A.
- The Procter and Gamble Company
- Allergan plc
- L'Oreal Group
- Beiersdorf AG
- Kao Corporation (Kanebo Cosmetics Inc.)
- Estee Lauder Companies Inc.
- Shiseido Company
Methodology
LOADING...
